StockData

Aurora Cannabis vs Intercure

ACB and INCR side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How ACB and INCR compare

Intercure grew revenue faster over the last twelve months (13.1% versus 11.0% for Aurora Cannabis).

Aurora Cannabis scores higher on the StockData Score (6 against 3 for Intercure), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricACBINCR
Size and price
Share price$4.61$3.79
Change, 1 year5.0%−44.3%
Change, 5 years−93.2%−90.4%
Beta (5Y)0.70–
StockData Score
Total score6 (better)3
Valuation score00
Growth score11
Performance score02 (better)
Health score5 (better)0
Dividend score00
Growth
Revenue growth (TTM)11.0%13.1% (better)
Revenue growth, 5Y average5.5%33.0% (better)
EPS growth (TTM)−5450%–
Profitability
Gross margin42.6% (better)12.3%
Operating margin–−10.1%
Net margin–−13.2%
FCF margin–4.9%
Return on equity–−9.0%
Return on invested capital–−4.0%
Financial health
Debt / equity0.000.49 (better)
Current ratio5.94–
Piotroski F-score–5
Ownership
Held by institutions8.9%0.22%
Held by insiders0.00%30.8%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.